| Date Filed | Type | Description |
| 07/17/2023 |
3/A
| Henderson Jane (CFO) has filed a Form 3/A on Apogee Therapeutics, Inc. |
| 07/13/2023 |
3
| Henderson Jane (CFO) has filed a Form 3 on Apogee Therapeutics, Inc. |
| 07/13/2023 |
4
| Henderson Jane (Director) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Disposed/sold 22,088 shares
@ $0
Disposed/sold 7,500 restricted stock units
@ $0
Disposed/sold 32,000 options to buy
@ $2.85, valued at
$91.2k
Disposed/sold 16,000 options to buy
@ $2.775, valued at
$44.4k
Disposed/sold 16,000 options to buy
@ $1.39, valued at
$22.2k
Disposed/sold 16,000 options to buy
@ $4.14, valued at
$66.2k
Disposed/sold 15,500 options to buy
@ $6.82, valued at
$105.7k
Disposed/sold 23,186 options to buy
@ $9.94, valued at
$230.5k
|
|
| 06/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/19/2023 |
4
| Henderson Jane (Director) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Granted 7,500 restricted stock units
@ $0 |
|
| 05/15/2023 |
4
| Henderson Jane (Director) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Exercised 14,588 restricted stock units
@ $0 |
|
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2022 |
4
| Henderson Jane (CFO) has filed a Form 4 on Adagio Therapeutics, Inc.|
Txns:
| Granted 175,000 options to buy
@ $6.78, valued at
$1.2M
|
|
| 08/05/2021 |
3
| Henderson Jane (CFO) has filed a Form 3 on Adagio Therapeutics, Inc. |
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2020 |
4
| Henderson Jane (Director) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Granted 16,000 options to buy
@ $4.14, valued at
$66.2k
|
|
| 06/02/2020 |
4
| Henderson Jane (Director) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Granted 13,000 options to buy
@ $25.2, valued at
$327.6k
|
|
| 05/08/2020 |
4
| Henderson Jane (Director) has filed a Form 4 on Sesen Bio, Inc.|
Txns:
| Granted 59,000 options
@ $0.6294, valued at
$37.1k
|
|
| 06/21/2019 |
4
| Henderson Jane (Director) has filed a Form 4 on Sesen Bio, Inc.|
Txns:
| Granted 52,500 options
@ $1.48, valued at
$77.7k
|
|
| 06/19/2019 |
3
| Henderson Jane (Director) has filed a Form 3 on Akero Therapeutics, Inc. |
| 05/16/2019 |
4
| Henderson Jane (Director) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Granted 16,000 options to buy
@ $1.39, valued at
$22.2k
|
|
| 07/11/2018 |
4
| Henderson Jane (Director) has filed a Form 4 on Ophthotech Corp.|
Txns:
| Granted 16,000 options to buy
@ $2.775, valued at
$44.4k
|
|
| 06/14/2018 |
4
| Henderson Jane (Director) has filed a Form 4 on Sesen Bio, Inc.|
Txns:
| Granted 52,500 options
@ $2.24, valued at
$117.6k
|
|
| 03/26/2018 |
4
| Henderson Jane (Sr. V.P. & CFO, Corp. Dev.) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Sold 19,900 shares
@ $21.07, valued at
$419.3k
Sold 11,200 shares
@ $20.52, valued at
$229.8k
Exercised 19,900 options to buy
@ $11.97, valued at
$238.2k
Exercised 11,200 options to buy
@ $11.97, valued at
$134.1k
|
|
| 03/20/2018 |
4
| Henderson Jane (CFO & SVP, Corp. Dev.) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Sold 15,416 shares
@ $22.15, valued at
$341.5k
Sold 1,900 shares
@ $21.76, valued at
$41.3k
Exercised 15,416 options to buy
@ $11.97, valued at
$184.5k
Exercised 1,900 options to buy
@ $11.97, valued at
$22.7k
|
|
| 03/09/2018 |
4
| Henderson Jane (Sr. V.P. & CFO) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 65,000 options to buy
@ $28.72, valued at
$1.9M
|
|
| 01/17/2018 |
4
| Henderson Jane (Director) has filed a Form 4 on Ophthotech Corp.|
Txns:
| Granted 32,000 options to buy
@ $2.85, valued at
$91.2k
|
|
| 01/17/2018 |
3
| Henderson Jane (Director) has filed a Form 3 on Ophthotech Corp. |
| 05/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/05/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 06/10/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |